Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study
Allergy2017Vol. 72(6), pp. 857–865
Citations Over TimeTop 1% of 2017 papers
Jean Bousquet, Davide Caimmi, Anna Bedbrook, M. Bewick, Peter W. Hellings, Philippe Devillier, S. Arnavielhe, Claus Bachert, Karl‐Christian Bergmann, Giorgio Walter Canonica, Niels H. Chavannes, Álvaro A. Cruz, Ronald Dahl, Pascal Demoly, Govert de Vries, E. Mathieu‐Dupas, Antjie Fink-Wagner, João Fonseca, N. Guldemond, Tari Haahtela, B. Hellqvist-Dahl, J. Just, Thomas Keil, Ludger Klimek, Marek L. Kowalski, M. Kuitunen, Piotr Kuna, Violeta Kvedarienė, D. Laune, Ana Margarida Pereira, P. Carreiro‐Martins, Erik Melén, Mário Morais‐Almeida, Joaquim Mullol, Antonella Muraro, Ruth Murray, Luís Nogueira‐Silva, Nikolaos G. Papadopoulos, Giovanni Passalacqua, F. Portejoie, David Price, Dermot Ryan, Bolesław Samoliński, Aziz Sheikh, Valérie Siroux, O. Spranger, A. Todo Bom, Peter Valentin Tomazic, A. Valero, Erkka Valovirta, Arūnas Valiulis, Olivier Vandenplas, Stan van der Meulen, M. van Eerd, Magnus Wickman, Torsten Zuberbier
Abstract
This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods.
Related Papers
- → Efficacy and safety of herbal steam bath in allergic rhinitis: a randomized controlled trial(2017)12 cited
- → Desloratadine relieves nasal congestion and improves quality‐of‐life in persistent allergic rhinitis(2009)27 cited
- → Effect of Montelukast on the Symptom Severity Score of Allergic Rhinitis(2020)6 cited
- → Phenotyping Non-Allergic Rhinitis (NAR) Patients: Application of the Major Non-Allergic Rhinitis (NAR) Triggers under Controlled Conditions of an Environmental Exposure Chamber (EEC) reveal NAR Patient Heterogeneity(2010)1 cited
- フェキソフェナジン塩酸塩60 mg/フェニレフリン塩酸塩10 mg 配合剤(FEX60/PE10 錠)のアレルギー性鼻炎患者に対する有効性および安全性の検討―多施設共同,オープンラベル試験―(2017)